GL1X · GenesisL1 explorer

MolNFT v1 · #157082 · protein

Crystal structure of mouse btk kinase domain in complex with compound 9A

6MNY · Tyrosine-protein kinase: “Crystal structure of mouse btk kinase domain in complex with compound 9A”. X-ray diffraction, 1 ligand (JVP), 4 pockets (best druggability 0.82). MolNFT v1 #157082 on GenesisL1: 3D structure, binding sites…

PDB
6MNY
Type
protein
Length
505 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase
EC
2.7.10.2
UniProt
Q7TMU1
Ligands
JVP
Pockets
4 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 43% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase (EC 2.7.10.2)protein25243% helix, 19% strandQ7TMU1
BTyrosine-protein kinase (EC 2.7.10.2)protein25343% helix, 18% strandQ7TMU1

Ligands and binding sites

  • JVP · 5-amino-1-[(3R)-1-cyanopiperidin-3-yl]-3-[4-(2,4-difluorophenoxy)phenyl]-1H-pyrazole-4-carboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110830.820.8388empty
22790.700.8541JVP
3540.430.8316empty
4780.340.7517empty

Interfaces

1 interface between chains.

  • A–B · 681 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 6MNY · Crystal structure of mouse BTK kinase domain in complex with compound 9a · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.